Madhanagopal Anandapadamanaban
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Madhanagopal Anandapadamanaban has a total of 138 co-authors. Here are the top co-authors by number of shared publications:
- Roger L. Williams
MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge, CB2 0QH, UK
6 shared publications - Maria Sunnerhagen
Department of Physics, Chemistry and Biology, Division of Chemistry, Linköping University, Linköping, Sweden
5 shared publications Björn Wallner
Division of Bioinformatics, Department of Physics, Chemistry and Biology, Linköping University, Linköping, Sweden
3 shared publications- Marie Wahren-Herlenius
Division of Rheumatology, Department of Medicine, Karolinska Institutet , Stockholm
3 shared publications - Martin Moche
Structural Genomics Consortium, Karolinska Institutet, Stockholm, Sweden
3 shared publications - Olga Perisic
MRC Laboratory of Molecular Biology
3 shared publications
Latest Publications
- Open Access
mTOR signalling, not clock gene rhythms, organises daily physiology
Summary: Daily rhythms in mammalian physiology are widely attributed to rhythmic transcription of “clock-controlled genes” driven by the circadian transcriptional/translational feedback loop (TTFL). Here we show that daily physiology can be uncoupled from the TTFL: inhibiting the mechanistic target of rapamycin (mTOR) abolishes most daily variation in cellular and organismal physiology, whilst clock protein rhythms persist. In cultured cells and mouse liver, functional rhythms are lost, including the proteome, RNA abundance, substrate utilisation and drug metabolism. In forebrain, most daily variation in protein abundance and phosphorylation is lost, yet locomotor activity and sleep-wake architecture are largely preserved in mice and zebrafish. PERIOD2 binds mTORC1 and limits its activity, providing a route by which clock proteins shape daily mTOR signalling. mTOR inhibition preferentially suppresses output over clock gene rhythms in Arabidopsis and Neurospora . We conclude that mTOR is a conserved conduit through which circadian and environmental timing impose daily organisation on physiology.
Open AccessmTOR signalling, not clock gene rhythms, organises daily physiology
Summary: Daily rhythms in mammalian physiology are widely attributed to rhythmic transcription of “clock-controlled genes” driven by the circadian transcriptional/translational feedback loop (TTFL). Here we show that daily physiology can be uncoupled from the TTFL: inhibiting the mechanistic target of rapamycin (mTOR) abolishes most daily variation in cellular and organismal physiology, whilst clock protein rhythms persist. In cultured cells and mouse liver, functional rhythms are lost, including the proteome, RNA abundance, substrate utilisation and drug metabolism. In forebrain, most daily variation in protein abundance and phosphorylation is lost, yet locomotor activity and sleep-wake architecture are largely preserved in mice and zebrafish. PERIOD2 binds mTORC1 and limits its activity, providing a route by which clock proteins shape daily mTOR signalling. mTOR inhibition preferentially suppresses output over clock gene rhythms in Arabidopsis and Neurospora . We conclude that mTOR is a conserved conduit through which circadian and environmental timing impose daily organisation on physiology.
- Open Access
Structural basis for a phosphoinositide-driven mTORC2-AKT positive feedback loop
The mammalian target of rapamycin complex 2 (mTORC2) regulates metabolism, growth, survival and cytoskeletal organization, yet its activation mechanism is poorly understood. We show that mTORC2 is directly activated by membranes and our cryo-electron tomography structure of membrane-bound mTORC2 reveals the N-HEAT region of mTOR is at the major membrane interface. mTORC2 is further potently activated by a positive feedback loop involving reciprocal phosphorylation of mTORC2 and its substrate kinase AKT. Cryo-EM structures of dephosphorylated, autophosphorylated and AKT-phosphorylated mTORC2 reveal structural changes in the SIN1 subunit, regulating an autoinhibitory anchor. Reconstitution of the PDK1-AKT-mTORC2 hub on PIP3-containing membranes shows that PDK1/PIP3-dependent AKT activation drives SIN1-T86 phosphorylation, enabling mTORC2 to phosphorylate S473 of AKT's hydrophobic motif, establishing a PI3K-dependent, phosphorylation-driven positive feedback loop at the membrane.
Open AccessStructural basis for a phosphoinositide-driven mTORC2-AKT positive feedback loop
The mammalian target of rapamycin complex 2 (mTORC2) regulates metabolism, growth, survival and cytoskeletal organization, yet its activation mechanism is poorly understood. We show that mTORC2 is directly activated by membranes and our cryo-electron tomography structure of membrane-bound mTORC2 reveals the N-HEAT region of mTOR is at the major membrane interface. mTORC2 is further potently activated by a positive feedback loop involving reciprocal phosphorylation of mTORC2 and its substrate kinase AKT. Cryo-EM structures of dephosphorylated, autophosphorylated and AKT-phosphorylated mTORC2 reveal structural changes in the SIN1 subunit, regulating an autoinhibitory anchor. Reconstitution of the PDK1-AKT-mTORC2 hub on PIP3-containing membranes shows that PDK1/PIP3-dependent AKT activation drives SIN1-T86 phosphorylation, enabling mTORC2 to phosphorylate S473 of AKT's hydrophobic motif, establishing a PI3K-dependent, phosphorylation-driven positive feedback loop at the membrane.
- Open Access
Multifocal, multiphenotypic tumours arising from an MTOR mutation acquired in early embryogenesis
Embryogenesis is a vulnerable time. Mutations in developmental cells can result in the wide dissemination of cells predisposed to disease within mature organs. We characterised the evolutionary history of four synchronous renal tumours from a 14-year-old girl, timing their shared origin to a multipotent embryonic cell committed to the right kidney, around 4 weeks post-conception. Their shared MTOR mutation, absent from normal tissues, enhances protein flexibility, which enables a FAT domain hinge to dramatically increase activity of mTORC1 and mTORC2. Developmental mutations, not usually detected in traditional genetic screening, have vital clinical importance in guiding prognosis, targeted treatment, and family screening decisions for paediatric tumours.
Open AccessMultifocal, multiphenotypic tumours arising from an MTOR mutation acquired in early embryogenesis
Embryogenesis is a vulnerable time. Mutations in developmental cells can result in the wide dissemination of cells predisposed to disease within mature organs. We characterised the evolutionary history of four synchronous renal tumours from a 14-year-old girl, timing their shared origin to a multipotent embryonic cell committed to the right kidney, around 4 weeks post-conception. Their shared MTOR mutation, absent from normal tissues, enhances protein flexibility, which enables a FAT domain hinge to dramatically increase activity of mTORC1 and mTORC2. Developmental mutations, not usually detected in traditional genetic screening, have vital clinical importance in guiding prognosis, targeted treatment, and family screening decisions for paediatric tumours.
- Open Access
- 14 September 2021
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 10
Bipartite binding and partial inhibition links DEPTOR and mTOR in a mutually antagonistic embrace
The mTORC1 kinase complex regulates cell growth, proliferation, and survival. Because mis-regulation of DEPTOR, an endogenous mTORC1 inhibitor, is associated with some cancers, we reconstituted mTORC1 with DEPTOR to understand its function. We find that DEPTOR is a unique partial mTORC1 inhibitor that may have evolved to preserve feedback inhibition of PI3K. Counterintuitively, mTORC1 activated by RHEB or oncogenic mutation is much more potently inhibited by DEPTOR. Although DEPTOR partially inhibits mTORC1, mTORC1 prevents this inhibition by phosphorylating DEPTOR, a mutual antagonism that requires no exogenous factors. Structural analyses of the mTORC1/DEPTOR complex showed DEPTOR’s PDZ domain interacting with the mTOR FAT region, and the unstructured linker preceding the PDZ binding to the mTOR FRB domain. The linker and PDZ form the minimal inhibitory unit, but the N-terminal tandem DEP domains also significantly contribute to inhibition.
- 14 September 2021
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 10
Open AccessBipartite binding and partial inhibition links DEPTOR and mTOR in a mutually antagonistic embrace
The mTORC1 kinase complex regulates cell growth, proliferation, and survival. Because mis-regulation of DEPTOR, an endogenous mTORC1 inhibitor, is associated with some cancers, we reconstituted mTORC1 with DEPTOR to understand its function. We find that DEPTOR is a unique partial mTORC1 inhibitor that may have evolved to preserve feedback inhibition of PI3K. Counterintuitively, mTORC1 activated by RHEB or oncogenic mutation is much more potently inhibited by DEPTOR. Although DEPTOR partially inhibits mTORC1, mTORC1 prevents this inhibition by phosphorylating DEPTOR, a mutual antagonism that requires no exogenous factors. Structural analyses of the mTORC1/DEPTOR complex showed DEPTOR’s PDZ domain interacting with the mTOR FAT region, and the unstructured linker preceding the PDZ binding to the mTOR FRB domain. The linker and PDZ form the minimal inhibitory unit, but the N-terminal tandem DEP domains also significantly contribute to inhibition.
- Open Access
- 13 May 2020
- Published by Springer Nature in Nature Communications
- Vol. 11 (1) , 1-16
Molecular determinants underlying functional innovations of TBP and their impact on transcription initiation
TATA-box binding protein (TBP) is required for every single transcription event in archaea and eukaryotes. It binds DNA and harbors two repeats with an internal structural symmetry that show sequence asymmetry. At various times in evolution, TBP has acquired multiple interaction partners and different organisms have evolved TBP paralogs with additional protein regions. Together, these observations raise questions of what molecular determinants (i.e. key residues) led to the ability of TBP to acquire new interactions, resulting in an increasingly complex transcriptional system in eukaryotes. We present a comprehensive study of the evolutionary history of TBP and its interaction partners across all domains of life, including viruses. Our analysis reveals the molecular determinants and suggests a unified and multi-stage evolutionary model for the functional innovations of TBP. These findings highlight how concerted chemical changes on a conserved structural scaffold allow for the emergence of complexity in a fundamental biological process.
- 13 May 2020
- Published by Springer Nature in Nature Communications
- Vol. 11 (1) , 1-16
Open AccessMolecular determinants underlying functional innovations of TBP and their impact on transcription initiation
TATA-box binding protein (TBP) is required for every single transcription event in archaea and eukaryotes. It binds DNA and harbors two repeats with an internal structural symmetry that show sequence asymmetry. At various times in evolution, TBP has acquired multiple interaction partners and different organisms have evolved TBP paralogs with additional protein regions. Together, these observations raise questions of what molecular determinants (i.e. key residues) led to the ability of TBP to acquire new interactions, resulting in an increasingly complex transcriptional system in eukaryotes. We present a comprehensive study of the evolutionary history of TBP and its interaction partners across all domains of life, including viruses. Our analysis reveals the molecular determinants and suggests a unified and multi-stage evolutionary model for the functional innovations of TBP. These findings highlight how concerted chemical changes on a conserved structural scaffold allow for the emergence of complexity in a fundamental biological process.
- 11 October 2019
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 366 (6462) , 203-210
Architecture of human Rag GTPase heterodimers and their complex with mTORC1
Mastering regulation: The mechanistic target of rapamycin complex 1 (mTORC1) is known as the master kinase, acknowledging its key role in integrating multiple signals to regulate cell growth. When nutrients are abundant, heterodimers of Rag, a class of small guanosine triphosphatase, bind to mTORC1 and recruit it to the lysosome. Here, other signaling pathways converge on the mTORC1 complex. Anandapadamanaban et al. determined cryo–electron microscopy and crystal structures of a RagA/RagC heterodimer. The structures, together with dynamic studies, explain the nucleotide states required for binding to mTORC1 and support a mechanism for conformational communication between the RagA and RagC subunits in the heterodimer. RagA/RagC binding causes no conformational change in mTORC1, which is consistent with the idea that mTORC1 must sense additional growth regulators before it is activated. Science , this issue p. 203
- 11 October 2019
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 366 (6462) , 203-210
Architecture of human Rag GTPase heterodimers and their complex with mTORC1
Mastering regulation: The mechanistic target of rapamycin complex 1 (mTORC1) is known as the master kinase, acknowledging its key role in integrating multiple signals to regulate cell growth. When nutrients are abundant, heterodimers of Rag, a class of small guanosine triphosphatase, bind to mTORC1 and recruit it to the lysosome. Here, other signaling pathways converge on the mTORC1 complex. Anandapadamanaban et al. determined cryo–electron microscopy and crystal structures of a RagA/RagC heterodimer. The structures, together with dynamic studies, explain the nucleotide states required for binding to mTORC1 and support a mechanism for conformational communication between the RagA and RagC subunits in the heterodimer. RagA/RagC binding causes no conformational change in mTORC1, which is consistent with the idea that mTORC1 must sense additional growth regulators before it is activated. Science , this issue p. 203
- Open Access
- 1 July 2019
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 294 (30) , 11404-11419
E3 ubiquitin-protein ligase TRIM21-mediated lysine capture by UBE2E1 reveals substrate-targeting mode of a ubiquitin-conjugating E2
- 1 July 2019
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 294 (30) , 11404-11419
Open AccessE3 ubiquitin-protein ligase TRIM21-mediated lysine capture by UBE2E1 reveals substrate-targeting mode of a ubiquitin-conjugating E2
- Open Access
- 31 May 2018
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 7
IP6 is an HIV pocket factor that prevents capsid collapse and promotes DNA synthesis
The HIV capsid is semipermeable and covered in electropositive pores that are essential for viral DNA synthesis and infection. Here, we show that these pores bind the abundant cellular polyanion IP6, transforming viral stability from minutes to hours and allowing newly synthesised DNA to accumulate inside the capsid. An arginine ring within the pore coordinates IP6, which strengthens capsid hexamers by almost 10°C. Single molecule measurements demonstrate that this renders native HIV capsids highly stable and protected from spontaneous collapse. Moreover, encapsidated reverse transcription assays reveal that, once stabilised by IP6, the accumulation of new viral DNA inside the capsid increases >100 fold. Remarkably, isotopic labelling of inositol in virus-producing cells reveals that HIV selectively packages over 300 IP6 molecules per infectious virion. We propose that HIV recruits IP6 to regulate capsid stability and uncoating, analogous to picornavirus pocket factors. HIV-1/IP6/capsid/co-factor/reverse transcription.
- 31 May 2018
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 7
Open AccessIP6 is an HIV pocket factor that prevents capsid collapse and promotes DNA synthesis
The HIV capsid is semipermeable and covered in electropositive pores that are essential for viral DNA synthesis and infection. Here, we show that these pores bind the abundant cellular polyanion IP6, transforming viral stability from minutes to hours and allowing newly synthesised DNA to accumulate inside the capsid. An arginine ring within the pore coordinates IP6, which strengthens capsid hexamers by almost 10°C. Single molecule measurements demonstrate that this renders native HIV capsids highly stable and protected from spontaneous collapse. Moreover, encapsidated reverse transcription assays reveal that, once stabilised by IP6, the accumulation of new viral DNA inside the capsid increases >100 fold. Remarkably, isotopic labelling of inositol in virus-producing cells reveals that HIV selectively packages over 300 IP6 molecules per infectious virion. We propose that HIV recruits IP6 to regulate capsid stability and uncoating, analogous to picornavirus pocket factors. HIV-1/IP6/capsid/co-factor/reverse transcription.
- 29 November 2017
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 56 (49) , 6411-6412
Ragtime Regulation: Mechanism of TORC1 Activation in Nutrient Sensing
- 29 November 2017
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 56 (49) , 6411-6412
Ragtime Regulation: Mechanism of TORC1 Activation in Nutrient Sensing